Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies

International Journal of Gynecological Cancer

Volumn 25, Issue 4, 2015, Pages 751-757

  Hareyama, Hitoshi ^a   Hada, Kenichi ^a   Goto, Kumiko ^a   Watanabe, Sawako ^a   Hakoyama, Minako ^a   Oku, Kikuo ^a   Hayakashi, Yukitoki ^a   Hirayama, Emi ^a   Okuyama, Kazuhiko ^a  

^a SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

Cellulitis; Lymphedema; Para aortic node; Pelvic node

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CELLULITIS; CYSTIC LYMPHANGIOMA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENDOMETRIUM CANCER; FEMALE; FEMALE GENITAL TRACT CANCER; HUMAN; HYSTERECTOMY; INCIDENCE; LOWER EXTREMITY LYMPHEDEMA; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OVARY CANCER; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL RISK; UTERINE CERVIX CANCER; ADVERSE EFFECTS; CANCER STAGING; CLASSIFICATION; COMPLICATION; DIAGNOSIS; FOLLOW UP; GENITAL NEOPLASMS, FEMALE; LEG; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, FEMALE; HUMANS; LOWER EXTREMITY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHEDEMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84928889944     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000405     Document Type: Article

References (32)

1. Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer. 1998;83:2821-2827
2. Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103:714-718
3. Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Lymphedema and bladder-emptying difficulties after radical hysterectomy for early cervical cancer and among population controls. Int J Gynecol Cancer. 2006;16:1130-1139
4. Tanaka T, Ohki N, Kojima A, et al. Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey. Int J Gynecol Cancer. 2007;17:460-464
5. Tada H, Teramukai S, Fukushima M, et al. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009;9:47
6. Kim JH, Choi JH, Ki EY, et al. Incidence and risk factors of lower-extremity lymphedema after surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer. Int J Cancer. 2012;22:686-691
7. Todo Y, Yamamoto R, Minobe S, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol. 2010;119:60-64
8. Füller J, Guderian D, Köhler C, et al. Lymph edema of the lower extremities after lymphadenectomy and radiotherapy for cervical cancer. Strahlenther Onkol. 2008;184:206-211
9. Beesley V, Janda M, Eakin E, et al. Lymphedema after gynecological cancer treatment. Prevalence, correlates, and supportive care needs. Cancer. 2007;109:2607-2614
10. Hareyama H, Ito K, Watanabe S, et al. Factors influencing the number of pelvic and para-aortic lymph nodes removed in surgical treatment of endometrial and ovarian cancer. Int J Gynecol Cancer. 2012;22:1577-1584
11. Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in stage IB, IIA and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85:1547-1554
12. Hirahatake K, Hareyama H, Sakuragi N, et al. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol. 1997;65:82-87
13. Tsumura N, Sakuragi N, Hareyama H, et al. The distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer. 1998;79:526-530
14. Abu-Rustum NR, Barakat RR. Observation on the role of circumflex iliac node resection and etiology of lower extremity lymphedema following pelvic lympadenectomy for gynecologic malignancy. Gynecol Oncol. 2007;106:4-5
15. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology. 2003;36:84-91
16. Todo Y, Kato H, Kaneuchi M, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165-1172
17. Chan JK, Urban R, Cheung MK, et al. Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough?. A study of 11,443 patients. Cancer. 2007;109:2454-2460
18. Mahdi H, Thrall M, Kumar S, et al. The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients. J Surg Oncol. 2011;103:724-729
19. Chan JK, Kapp DS, Cheung MK, et al. The impact of the absolute number and ratio of survival of endometrioid uterine cancer patients. Br J Cancer. 2007;97:605-611
20. Soisson AP, Soper JT, Clarke-Pearson DL, et al. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 1990;37:390-395
21. Duewell S, Hagspiel KD, Zuber J, et al. Swollen lower extremity: role of MR imaging. Radiology. 1992;184:227-231
22. Takeishi M, Kojima M, Mori K, et al. Primary intrapelvic lymphaticovenular anastomosis following lymph node dissection. Ann Plast Surg. 2006;57:300-304
23. Ryan M, Stainton MC, Slaytor EK, et al. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol. 2003;43:148-151
24. Yuan Z, Chen L, Luo Q, et al. The role of radionuclide lymphoscintigraphy in extremity lymphedema. Ann Nucl Med. 2006;20:341-344
25. Hareyama H, Ito K, Hada K, et al. Reduction/prevention of lower extremity lymphedema after pelvic and para-aortic lymphadenectomy for patients with gynecologic malignancies. Ann Surg Oncol. 2012;19:268-273
26. Helyer LK, Varnic M, Le LW, et al. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J. 2010;16:48-54
27. Edwards TL. Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg. 2000;70:412-418
28. Goldberg JI, Wiechmann LI, Riedel ER, et al. Morbidity of sentinel node biopsy in breast cancer: the relationship between the number of excised lymph nodes and lymphedema. Ann Surg Oncol. 2010;17:3278-3286
29. Hoffman MS, Parsons M, Gunasekaran S, et al. Distal external iliac lymph nodes in early cervical cancer. Obstet Gynecol. 1999;94:391-394
30. Dankert J, Bouma J. Recurrent acute leg cellulitis after hysterectomy with pelvic lymphadenectomy. Br J Obstet Gynecol. 1987;94:788-790
31. Bouma J, Dankert J. Recurrent acute leg cellulitis in patients after radical vulvectomy. Gynecol Oncol. 1988;29:50-57
32. Japan Society of Gynecologic Oncology. The 2010 annual report of gynecologic oncology committee. Nissannpusi. 2012;64:1029-1141